Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Factor V Leiden mutation
|
46 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.100 | 0.966 | 29 | 1996 | 2019 | |||||
Thrombophilia
|
43 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.100 | 1.000 | 13 | 1995 | 2019 | |||||
Venous Thromboembolism
|
408 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.100 | 1.000 | 10 | 1999 | 2019 | |||||
Deep Vein Thrombosis
|
93 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.070 | 1.000 | 7 | 2000 | 2018 | |||||
Coronary Artery Disease
|
1577 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.040 | 1.000 | 4 | 1995 | 2018 | |||||
prothrombin gene mutation
|
5 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.040 | 1.000 | 4 | 2005 | 2012 | |||||
Activated Protein C Resistance
|
30 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 1995 | 2018 | |||||
Behcet Syndrome
|
243 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 1996 | 2013 | |||||
Coronary Arteriosclerosis
|
440 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.030 | 0.667 | 3 | 1995 | 2009 | |||||
Coronary heart disease
|
1178 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.030 | 0.667 | 3 | 1995 | 2009 | |||||
Miscarriage
|
56 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2005 | 2016 | |||||
Acute myocardial infarction
|
118 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2010 | 2016 | |||||
Anemia, Sickle Cell
|
138 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2006 | 2013 | |||||
Hyperhomocysteinemia
|
45 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2006 | 2013 | |||||
Inflammatory Bowel Diseases
|
605 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2002 | 2002 | |||||
Portal Vein Thrombosis
|
8 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2005 | 2015 | |||||
Protein S Deficiency
|
14 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2006 | 2017 | |||||
Sudden sensorineural hearing loss
|
38 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2006 | 2011 | |||||
Vertical Talus
|
20 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||
5,10-Methylenetetrahydrofolate reductase deficiency
|
6 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Amaurosis Fugax
|
2 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Antithrombin III Deficiency
|
52 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Arterial Occlusive Diseases
|
4 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 1999 | 1999 | |||||
beta Thalassemia
|
103 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Beta thalassemia intermedia
|
12 | 0.574 | 0.680 | 1 | 169546513 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2008 | 2008 |